UNSPSC 51285206: Trimethoprim sulfate

This classification denotes a urinary anti-infective agent with the molecular formula 2C14H18N4O3.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E377MF8EQ8, chemically known as 2,4-pyrimidinediamine, 5-((3,4-trimethoxyphenyl)methyl)-, sulfate (2:1) but more generally known as trimethoprim sulfate, which bears US NIH Compound Identifier 64936. European Medicines Agency schedules Trimethoprim sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15618MIG.

Most nations, for tariff and trade purposes, schedule trimethoprim sulfate under HS 29335995 and SITC 51576. SMILES: COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N.OS(=O)(=O)O.

UNSPSC 51285206 Trimethoprim sulfate, a Commodity code, nominally covers antibiotic pharmaceuticals but shows minimal recent state and local procurement activity aligned with that specific product. The recent opportunities tagged to this code instead reflect broader pharmaceutical and medical supply procurement across health departments, fire rescue operations, and cooperative purchasing alliances—driven by demand for generic pharmaceuticals, over-the-counter products, naloxone, emergency medical consumables, and direct-to-manufacturer prescription fulfillment models. State and local governments are buying these supplies through a mix of issuing bodies: county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). Repeat or standout buyers include MMCAP, which operates a formal RFP cycle for generic pharmaceuticals and OTC products serving multiple member jurisdictions, and county and municipal emergency-response and public-health divisions that procure medical and pharmaceutical supplies annually or through formal bid cycles.

Geographic activity spans Florida (Seminole County, Tampa), Texas (state-level through HHS), Minnesota and Oregon (through MMCAP), and the broader cooperative-purchasing network. Representative recent opportunities include the City of Tampa's IFB for medical and first aid supplies (169 line items, $700,000 estimated contract value, sealed bid due March 13, 2026, sheltered to certified Small Local Business Enterprises with a 5 percent bid discount cap of $10,000); Seminole County's IFB for naloxone and drug deactivation systems (1,900 units naloxone and 800 deactivation systems annually, quarterly deliveries, electronic bid submission due July 26, 2023); the Texas HHS Commission's RFI on direct-to-manufacturer prescriptions (posted April 3, 2026, response due same day, exploratory market intelligence for future RFP development); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (proposals due March 26, 2026, effective July 1, 2026, 75 percent weight on price competitiveness, requiring cGMP and DSCSA certification and relationships with authorized wholesalers AmerisourceBergen, Cardinal Health, and Morris & Dickson). The mismatch between the code's nominal scope (trimethoprim sulfate) and the breadth of pharmaceutical and medical-supply procurement activity suggests this code is applied loosely by some jurisdictions to cover entire drug categories rather than specific compounds.